catalyst

A Study To Evaluate The Safety And Efficacy Of PF-04958242 In Subjects With Cogn — primary completion

as of 2026-07-01
Monitor thisAsk about this
at a glance
2016-09-26 · Actual — This event happened.
Synthesized from structured facts only — each point cited above.

Event

What
A Study To Evaluate The Safety And Efficacy Of PF-04958242 In Subjects With Cogn — primary completion
Type
Trial Readout
Date
2016-09-26
Date type
ACTUAL
Phase
Phase 2
This event happened.
relationships
The graph out of here
trial
A Study To Evaluate The Safety And Efficacy Of PF-04958242 In Subjects With Cognitive Impairment Associated With Schizophrenia (CIAS)
trial